Pharmaceutical Technology
APRIL 24, 2023
With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.
Pharmaceutical Technology
MARCH 30, 2023
The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 15, 2022
The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. The documents state that a partnership with a CMO would be cheaper than the state directly manufacturing insulin. Prices would be “a fraction of the $300 per vial prices charged by insulin manufacturers.”.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Streamlined development, flexibility in manufacturing, and improved product quality at reduced costs, while gaining access to capabilities and capacity are some of the factors fuelling the pharmaceutical solid dosage contract manufacturing market. Growth of oral solid dosage contract manufacturing in the pharmaceutical industry.
Pharmaceutical Technology
AUGUST 30, 2022
Only a limited number of international pharma companies, however, operate manufacturing sites in the country. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America. French and Italian manufacturers have two companies in Brazil.
Pharmaceutical Technology
DECEMBER 6, 2022
Many companies are now prioritising investments in containment systems, GlobalData research shows. Between 2018 and 2020, 58% of the small molecule API contract manufacturing sites purchased worldwide offered containment. But containment is not only important at commercial-stage manufacturing.
pharmaphorum
NOVEMBER 12, 2020
UCB has made a new foray into the gene therapy space, buying fellow Belgium-based company Handl to get control of its adeno-associated virus (AAV) capsid delivery platform and two research programmes in neurodegenerative diseases. The post UCB revs up its gene therapy drive with Handl acquisition appeared first on.
Expert insights. Personalized for you.
130 
Let's personalize your content